| Induction by antigen of intrathymic apoptosis of CD4+ CD8+ TCRlo thymocytes in vivo KM Murphy, AB Heimberger, DY Loh Science 250 (4988), 1720-1723, 1990 | 2152 | 1990 |
| Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment Q Wang, B Hu, X Hu, H Kim, M Squatrito, L Scarpace, AC DeCarvalho, ... Cancer cell 32 (1), 42-56. e6, 2017 | 1464 | 2017 |
| Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma KPL Bhat, V Balasubramaniyan, B Vaillant, R Ezhilarasan, K Hummelink, ... Cancer cell 24 (3), 331-346, 2013 | 1082 | 2013 |
| Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. CS Hsieh, AB Heimberger, JS Gold, A O'Garra, KM Murphy Proceedings of the National Academy of Sciences 89 (13), 6065-6069, 1992 | 968 | 1992 |
| Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma JH Sampson, AB Heimberger, GE Archer, KD Aldape, AH Friedman, ... Journal of clinical oncology 28 (31), 4722, 2010 | 893 | 2010 |
| High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types DJ McGrail, PG Pilié, NU Rashid, L Voorwerk, M Slagter, M Kok, ... Annals of Oncology 32 (5), 661-672, 2021 | 675 | 2021 |
| Glioma cancer stem cells induce immunosuppressive macrophages/microglia A Wu, J Wei, LY Kong, Y Wang, W Priebe, W Qiao, R Sawaya, ... Neuro-oncology 12 (11), 1113-1125, 2010 | 673 | 2010 |
| The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses SF Hussain, D Yang, D Suki, K Aldape, E Grimm, AB Heimberger Neuro-oncology 8 (3), 261-279, 2006 | 653 | 2006 |
| Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial A Mahajan, S Ahmed, MF McAleer, JS Weinberg, J Li, P Brown, S Settle, ... The lancet oncology 18 (8), 1040-1048, 2017 | 651 | 2017 |
| Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients AB Heimberger, R Hlatky, D Suki, D Yang, J Weinberg, M Gilbert, ... Clinical cancer research 11 (4), 1462-1466, 2005 | 593 | 2005 |
| PD-L1 expression and prognostic impact in glioblastoma EK Nduom, J Wei, NK Yaghi, N Huang, LY Kong, K Gabrusiewicz, X Ling, ... Neuro-oncology 18 (2), 195-205, 2015 | 561 | 2015 |
| Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype K Gabrusiewicz, B Rodriguez, J Wei, Y Hashimoto, LM Healy, SN Maiti, ... JCI insight 1 (2), 2016 | 422 | 2016 |
| Tuning sensitivity of CAR to EGFR density limits recognition of normal tissue while maintaining potent antitumor activity HG Caruso, LV Hurton, A Najjar, D Rushworth, S Ang, S Olivares, T Mi, ... Cancer research 75 (17), 3505-3518, 2015 | 410 | 2015 |
| A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study J Schuster, RK Lai, LD Recht, DA Reardon, NA Paleologos, MD Groves, ... Neuro-oncology 17 (6), 854-861, 2015 | 410 | 2015 |
| Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma CE Pelloski, KV Ballman, AF Furth, L Zhang, E Lin, EP Sulman, K Bhat, ... Journal of Clinical Oncology 25 (16), 2288-2294, 2007 | 379 | 2007 |
| Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma JH Sampson, KD Aldape, GE Archer, A Coan, A Desjardins, AH Friedman, ... Neuro-oncology 13 (3), 324-333, 2011 | 378 | 2011 |
| Altered adenosine-to-inosine RNA editing in human cancer N Paz, EY Levanon, N Amariglio, AB Heimberger, Z Ram, S Constantini, ... Genome research 17 (11), 1586-1595, 2007 | 375 | 2007 |
| Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy TR Hodges, M Ott, J Xiu, Z Gatalica, J Swensen, S Zhou, JT Huse, ... Neuro-oncology 19 (8), 1047-1057, 2017 | 360 | 2017 |
| Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas AB Heimberger, M Abou-Ghazal, C Reina-Ortiz, DS Yang, W Sun, W Qiao, ... Clinical Cancer Research 14 (16), 5166-5172, 2008 | 357 | 2008 |
| Immunosuppressive mechanisms in glioblastoma EK Nduom, M Weller, AB Heimberger Neuro-oncology 17 (suppl_7), vii9-vii14, 2015 | 352 | 2015 |
